PEOPLE - Becton Dickinson names two new executive vice-presidents:
This article was originally published in Clinica
Executive Summary
Becton Dickinson has named two new executive vice-presidents: Gary Cohen, currently president of worldwide sample collection and Becton Dickinson Europe, and Edward Ludwig, currently senior vice-president and chief financial officer. Mr Cohen remains responsible for Europe and takes on responsibility for the US multinational's injection systems, infusion therapy and consumer healthcare businesses. Mr Ludwig is responsible for the flow cytometry, tissue culture labware and microbiology and sample collection businesses as well as other non-US operations. Kenneth Weisshaar, president of worldwide consumer healthcare, becomes senior vice-president and CFO.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.